Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Nina Shah, Krina K. Patel, Elizabeth Budde et al.|Blood|2021

Cited by 4